R N Matthews, J H Colebatch. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAgranulocytosis/chemically inducedAnemia/chemically inducedBone Marrow/drug effectsBone Marrow CellsChildChild, PreschoolCyclophosphamide/therapeutic useCytarabine/therapeutic useDaunorubicin/administration & dosageDaunorubicin/adverse effectsDaunorubicin/therapeutic useDrug SynergismFemaleHemorrhage/chemically inducedHumansInfantInjections, IntravenousLeukemia, Lymphoid/drug therapyLeukemia, Myeloid/drug therapyMaleMercaptopurine/therapeutic useNeutrophilsPrednisolone/therapeutic useThrombocytopenia/chemically inducedVincristine/therapeutic use
Substances: See more » CytarabineVincristineCyclophosphamidePrednisoloneMercaptopurineDaunorubicin
Year: 1972 PMID: 4502569 PMCID: PMC1648077 DOI: 10.1136/adc.47.252.272
Source DB: PubMed Journal: Arch Dis Child ISSN: 0003-9888 Impact factor: 3.791